Agree that those of us who follow NNVC expect these types of results, but disagree about the significance of the PR. Both the market and the science need confirmation studies. In this case, an aggressive protocol was repeated and yielded the same results. This repetition of results eliminates the possibility of the previous results having been caused by some flaw in the original tests.
There was a program on PBS last night about cheetahs in refuges. It focused mainly on 2 animals. At one point a 3rd cheetah entered the story and had contracted rabies. Watching the animal's symptoms progress over several days in the story, I thought about RabiCide-HP and how that cheetah, one of only 10,000 left in the world would have a had chance at survival. The staff in the film had antibiotics and lots of other medications in their field kit, but nothing for Rabies. Then the a park ranger and the narrator, both of whom had been scratched by the infected cheetah had to endure anti-rabies treatment. Again I thought how different the story might be told had Rabicide-HP already been a part of the field kit.
News 
Market Data 
Discover 
